Despite either therapies address articular issues, Novo Retatrutide represents a therapeutic formulated metabolic conditions, acting through several pathways . In contrast , Zydis remains a lubricating substance therapy largely deployed to reduce osteoarthritis outcomes within the affected area. Therefore , their indications but treatment approach